During the past decade, Krannert Institute of Cardiology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 11 clinical trials were completed, i.e. on average, 220% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Krannert Institute of Cardiology" #1 sponsor was "Boston Scientific Corporation" with 4 trials, followed by "Medtronic Cardiac Rhythm and Heart Failure" with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored, "Brigham and Women's Hospital" with 2 trials sponsored and "Point Biomedical" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Krannert Institute of Cardiology" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator, "Albany Stratton VA Medical Center" with 1 trials as a collaborator, "Boston VA Research Institute, Inc." with 1 trials as a collaborator, "Cedars-Sinai Medical Center" with 1 trials as a collaborator and "Columbia University" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Krannert Institute of Cardiology" are "Coronary Artery Disease" (7 trials), "Atrial Fibrillation" (3 trials), "Cardiovascular Disease" (2 trials), "Heart Failure" (2 trials) and "Arrhythmia" (1 trials). Many other conditions were trialed in "Krannert Institute of Cardiology" in a lesser frequency.

Most popular intervention types in "Krannert Institute of Cardiology" are "Device" (12 trials), "Drug" (8 trials), "Procedure" (3 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "PB127 for injectable suspension" (2 trials), "Antiarrhythmic drug" (1 trials), "Aspirin" (1 trials), "Biomarker-guided care NT-proBNP" (1 trials) and "BuMA Supreme DES" (1 trials). Other intervention names were less common.

The vast majority of trials in "Krannert Institute of Cardiology" are 20 trials for "All" genders.

Currently, there are NaN active trials in "Krannert Institute of Cardiology". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Krannert Institute of Cardiology, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Krannert Institute of Cardiology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 7 trials that are defined as “Not Applicable".